Cera Sanitaryware Ltd
Cera Sanitaryware Ltd
Consumer GoodsKey Fundamentals
MicrocapSanitary WareConsumer GoodsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Cera Sanitaryware Ltd insights
50 extracted metrics + investor summaries across FY14–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
3- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 38.0%
Weaknesses
1- The company has delivered a poor sales growth of 11.3% over past five years.
Growth Rate
AI Analysis — Bull vs Bear
Cera Sanitaryware trades at a market cap of ₹7,914 Cr with a PE of 38.6x on FY25 revenue of ₹1,915 Cr (up just 2.4% YoY) and PAT of ₹247 Cr. The company is virtually debt-free with a consistent ROE of 15-18% over the past decade, but recent top-line and bottom-line growth have decelerated materially compared to its 5-year and 10-year CAGRs.
- Near-zero debt on balance sheet, giving financial flexibility and low interest cost even in a rising rate environment
- Consistent ROE track record of 15-18% over the past 10 years, with 5-year average at 18%
- Healthy dividend payout ratio of 38%, translating to a 1.23% yield providing shareholder returns even in periods of muted growth
- Long-term compounded profit CAGR of 10% over 10 years and 16% over 5 years demonstrates earnings compounding ability
- Q4 FY25 EBITDA margin improved to 18.3% vs 16.8% in Q4 FY24, indicating margin recovery in the most recent quarter
- 10-year revenue CAGR of 8% and 10-year stock CAGR of 10% show sustained long-term value creation
- FY26 revenue of ₹2,050 Cr (up 7% YoY) shows acceleration from FY25's 2.4% growth, indicating potential demand recovery
- TTM profit declined 15% YoY, a significant earnings deterioration for a company trading at 38.6x PE
- FY25 revenue grew only 2.4% YoY to ₹1,915 Cr, a sharp slowdown from the 5-year sales CAGR of 11%
- PE of 38.6x is elevated given the 3-year profit CAGR of -1%, implying the stock prices in growth that has not materialized recently
- FY26 EBITDA declined 9% YoY (₹322 Cr vs ₹353 Cr) despite 7% revenue growth, indicating margin pressure from input costs or competition
- Stock price CAGR of -7% over both 1-year and 3-year periods reflects sustained underperformance and investor de-rating
- 3-year compounded sales growth of only 4% suggests structural demand challenges in the core sanitaryware segment
- Price-to-book of 5.34x is demanding for a business where ROE has moderated from 18% (5-year avg) to 15% in the latest year
- Tiles segment revenue declined 10% YoY in Q4 FY24, indicating weakness in the diversification vertical
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Chief Business Officer resigns Jul 21
Ramesh Baliga, CBO-Polymers and Emerging Business India, resigned effective September 30, 2026. No successor announced yet, creating near-term leadership gap in polymers segment.
- Q1 FY27 earnings call scheduled Jul 27
Q1 FY27 results to be declared on August 7, 2026, with earnings conference call on August 8 at 10:30 AM IST.
- AGM approves FY26 financials, dividend Jul 23
28th AGM held on July 23, 2026, approved FY 2025-26 financial statements, declared dividend, and ratified cost auditor remuneration.
TL;DR: A quiet period for Cera Sanitaryware with routine corporate governance events dominating the news flow. The CBO resignation in the polymers segment is a mild concern given no successor has been named. Investors will look to the Q1 FY27 results on August 7 for clarity on demand trends and margin trajectory in the sanitaryware and faucets business.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 427 | 461 | 437 | 547 | 398 | 490 | 449 | 578 | 407 | 488 | 499 | 624 | 486 |
| Expenses | 358 | 387 | 377 | 455 | 342 | 420 | 390 | 472 | 354 | 421 | 448 | 526 | 437 |
| Operating Profit | 68 | 74 | 59 | 92 | 56 | 70 | 59 | 106 | 53 | 67 | 51 | 98 | 49 |
| OPM % | 16% | 16% | 14% | 17% | 14% | 14% | 13% | 18% | 13% | 14% | 10% | 16% | 10% |
| Other Income | 16 | 11 | 16 | 16 | 16 | 18 | 12 | 14 | 19 | 17 | -7 | 17 | 21 |
| Interest | 1 | 1 | 1 | 1 | 1 | 3 | 2 | 2 | 1 | 2 | 2 | 1 | 1 |
| Depreciation | 8 | 8 | 9 | 9 | 8 | 10 | 10 | 10 | 9 | 10 | 10 | 10 | 9 |
| PBT | 75 | 76 | 65 | 98 | 63 | 75 | 60 | 108 | 61 | 72 | 32 | 104 | 60 |
| Tax % | 25% | 25% | 22% | 23% | 25% | 10% | 23% | 21% | 24% | 22% | 27% | 25% | 24% |
| Net Profit | 56 | 57 | 51 | 75 | 47 | 68 | 46 | 86 | 47 | 57 | 24 | 77 | 45 |
| EPS in Rs | 43.34 | 43.74 | 39.12 | 57.69 | 36.11 | 52.79 | 35.56 | 66.35 | 36.08 | 43.92 | 18.35 | 59.97 | 35.13 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 822 | 917 | 1,011 | 1,182 | 1,344 | 1,209 | 1,202 | 1,442 | 1,803 | 1,871 | 1,915 | 2,050 | 2,097 |
| Expenses | 703 | 776 | 841 | 1,014 | 1,152 | 1,045 | 1,052 | 1,220 | 1,510 | 1,577 | 1,622 | 1,781 | 1,832 |
| Operating Profit | 119 | 141 | 171 | 168 | 191 | 164 | 150 | 221 | 293 | 295 | 293 | 269 | 265 |
| OPM % | 14% | 15% | 17% | 14% | 14% | 14% | 12% | 15% | 16% | 16% | 15% | 13% | 13% |
| Other Income | 5 | 10 | 11 | 14 | 15 | 14 | 22 | 17 | 25 | 59 | 59 | 45 | 48 |
| Interest | 8 | 5 | 5 | 5 | 3 | 4 | 4 | 5 | 5 | 5 | 7 | 6 | 6 |
| Depreciation | 15 | 16 | 18 | 22 | 23 | 33 | 33 | 30 | 30 | 34 | 39 | 39 | 39 |
| PBT | 101 | 129 | 158 | 154 | 180 | 141 | 134 | 203 | 282 | 314 | 306 | 269 | 268 |
| Tax % | 33% | 36% | 34% | 35% | 36% | 18% | 25% | 27% | 26% | 24% | 19% | 24% | — |
| Net Profit | 68 | 83 | 104 | 100 | 115 | 116 | 101 | 149 | 210 | 239 | 246 | 204 | 203 |
| EPS in Rs | 52.02 | 64.17 | 79.94 | 77.08 | 88.46 | 89.14 | 77.89 | 115 | 161 | 184 | 191 | 158 | 157 |
| Div. Payout % | 12% | 14% | 15% | 16% | 15% | 15% | 17% | 30% | 31% | 33% | 34% | 47% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 345 | 415 | 518 | 598 | 694 | 766 | 868 | 999 | 1,163 | 1,336 | 1,344 | 1,466 |
| Borrowings | 68 | 35 | 34 | 24 | 18 | 33 | 28 | 37 | 46 | 40 | 63 | 47 |
| Other Liabilities | 224 | 290 | 302 | 320 | 371 | 320 | 381 | 385 | 441 | 443 | 427 | 439 |
| Total Liabilities | 644 | 747 | 861 | 949 | 1,089 | 1,126 | 1,283 | 1,427 | 1,656 | 1,825 | 1,841 | 1,958 |
| Fixed Assets | 215 | 226 | 266 | 279 | 305 | 350 | 330 | 321 | 320 | 356 | 380 | 372 |
| CWIP | 8 | 4 | 0 | 5 | 11 | 1 | 1 | 1 | 17 | 13 | 11 | 7 |
| Investments | 48 | 67 | 119 | 139 | 212 | 262 | 513 | 567 | 669 | 807 | 702 | 815 |
| Other Assets | 374 | 449 | 475 | 525 | 561 | 512 | 440 | 539 | 649 | 649 | 749 | 764 |
| Total Assets | 644 | 747 | 861 | 949 | 1,089 | 1,126 | 1,283 | 1,427 | 1,656 | 1,825 | 1,841 | 1,958 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 41 | 116 | 112 | 72 | 114 | 123 | 262 | 98 | 156 | 228 | 116 | 212 |
| Investing | -117 | -38 | -92 | -36 | -102 | -76 | -243 | -70 | -101 | -140 | 128 | -88 |
| Financing | 76 | -48 | -20 | -34 | -27 | -53 | -13 | -21 | -59 | -80 | -258 | -115 |
| Net Cash Flow | -1 | 30 | 0 | 1 | -15 | -6 | 7 | 7 | -3 | 8 | -14 | 9 |
| Free Cash Flow | -43 | 92 | 58 | 24 | 73 | 82 | 253 | 85 | 123 | 167 | 89 | 192 |
| CFO/OP | 59 | 103 | 96 | 74 | 89 | 106 | 194 | 67 | 77 | 103 | 59 | 104 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 72 | 75 | 80 | 83 | 81 | 67 | 63 | 42 | 38 | 39 | 51 | 49 |
| Inventory Days | 120 | 109 | 98 | 104 | 101 | 128 | 96 | 154 | 167 | 148 | 163 | 139 |
| Days Payable | 46 | 48 | 58 | 50 | 53 | 52 | 81 | 104 | 93 | 75 | 77 | 77 |
| Cash Conversion Cycle | 145 | 137 | 120 | 136 | 129 | 142 | 78 | 92 | 112 | 112 | 137 | 111 |
| Working Capital Days | 43 | 47 | 43 | 56 | 58 | 66 | 30 | 37 | 43 | 44 | 65 | 61 |
| ROCE % | 32% | 30% | 31% | 26% | 27% | 19% | 16% | 22% | 26% | 25% | 22% | 19% |
Documents
Frequently Asked Questions about Cera Sanitaryware Ltd
What does Cera Sanitaryware Ltd do?
Where is Cera Sanitaryware Ltd (CERA) listed?
Which sector does Cera Sanitaryware Ltd belong to?
What is the market capitalisation of Cera Sanitaryware Ltd?
What is the PE ratio of Cera Sanitaryware Ltd?
What is the 52-week high and low of Cera Sanitaryware Ltd?
Does Cera Sanitaryware Ltd pay dividends?
What is the Return on Equity (ROE) of Cera Sanitaryware Ltd?
How can I research Cera Sanitaryware Ltd on Tapetide?
Company Information
Cera Sanitaryware Ltd is engaged in the business of manufacturing, selling and trading of various kinds of building products. It also has non-conventional wind & solar power for captive use in the state of Gujarat.[1]